cnbctv182h
BPCL shares are down 28% from peak but still expensive, says analyst
Brokerage firm Nuvama has highlighted concerns about BPCL's weak refining margin environment and LPG under-recoveries, which are impacting its earnings. Additionally, the high capital expenditure ...
BPCL Q3: Brokerages bullish on long-term growth outlook, await relief in upcoming Budget
CLSA upgraded the stock to 'hold', citing recent corrections, despite inventory losses and weaker refining margins.
阿思達克財經網4h
Trump Says He Knows Interest Rates Much Better Than Powell
US President Donald Trump questioned Federal Reserve Chairman Jerome Powell's decisions on interest rates, saying that he plans to talk to Powell at an appropriate time, foreign news reports said.
CLSA lowers Dr. Reddy's shares price target, citing lack of near-term growth triggers
CLSA analysts downgraded Dr. Reddy's Laboratories shares, trading on both BSE (DRRD:IN) and NYSE (NYSE:RDY), from a Hold to an Underperform rating, adjusting the price target from INR1,140 to INR1,090 ...
CLSA cuts Dr. Reddy's stock rating to Underperform
CLSA analysts downgraded Dr. Reddy's Laboratories shares, trading on both BSE (DRRD:IN) and NYSE (NYSE:RDY), from a Hold to an Underperform rating, adjusting the price target from INR1,140 to INR1,090 ...
CLSA selects Apollo Hospitals as top pick, says India's pharma set to outpace US growth
The firm expects mid-single-digit price erosion in generic drugs and heightened competition for key medications, potentially ...